Investigation of the effect of visceral adiposity index on venous clinical severity score in patients with chronic venous insufficiency

Abstract

Introduction

Chronic venous insufficiency (CVI) is a common disease affecting millions worldwide. Age, obesity, female gender, sedentary life, and long-standing at work causing orthostasis have been identified as predisposing factors.

Objective

The visceral adiposity index (VAI) is an important indicator of abdominal obesity. Various studies in the cardiovascular field have shown that it may be more predictive than body mass index (BMI).

Methods

A total of 171 consecutive patients diagnosed with low-grade (C0–C3) superficial primary CVI in our clinic, between November 2021 and December 2022, were included in this prospective study. Venous Clinical Severity Score (VCSS) values were calculated. The patients were divided into two groups according to their VCSS values (Group 1: VCSS ≤6 and Group 2: VCSS >6).

Results

There were 110 patients in Group 1 with a median age of 42 (18–50) years. There was no difference between the groups in terms of gender, smoking, hypertension frequency, height, weight, body mass index, hemoglobin values, lymphocyte, neutrophil, mean platelet volume, urea, creatinine, high-density lipoprotein, low-density lipoprotein, triglyceride, and total cholesterol values (p > .05). Multivariate logistic regression analysis was performed to reveal the predictive factors of high VCSS values in patients. As a result of the analysis, VAI (Odds Ratio (OR): 1.775; 95% Confidence Interval (CI): 1.389–2.269; p < .001) and CRP (OR: 2.641; 95% CI: 1.431–4.875; p = .002) values were identified as independent predictors in predicting high VCSS values.

Conclusion

This current study showed that high VAI values affect clinical complaints in patients with low-grade CVI. In line with our results, clinical recommendations can be made to reduce VAI values in low-stage CVI patients.

Keywords

Chronic venous insufficiency obesity visceral adiposity symptom

Get full access to this article

View all access options for this article.

References

Aydın

Engin

Türk

, et al. The effectiveness of different treatment methods in isolated telangiectasia and reticular vein treatment: a single-center prospective randomized study. Phlebology 2022; 37(1): 26–32.

Dogru-Huzmeli

Fansa

Cetisli-Korkmaz

, et al. Dancing: m than a therapy for patients with venous insufficiency. Vascular 2020; 28(2): 189–195.

Vlajinac

Marinkovic

Maksimovic

, et al. Body mass index and primary chronic venous disease--a cross-sectional study. Eur J Vasc Endovasc Surg 2013; 45(3): 293–298.

Donbaloğlu

. Does body mass index have an effect on clinical and pain after endovenous therapy? a retrospective study. Vascular 2022; 30(5): 969–976.

van Rij

De Alwis

Jiang

, et al. Obesity and impaired venous function. Eur J Vasc Endovasc Surg 2008; 35(6): 739–744.

Amato

Giordano

Galia

AlkaMeSy Study Group , et al. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 2010; 33(4): 920–922.

Willenberg

Clemens

Haegeli

, et al. The influence of abdominal pressure on lower extremity venous pressure and hemodynamics: a human in-vivo model simulating the effect of abdominal obesity. Eur J Vasc Endovasc Surg 2011; 41(6): 849–855.

Rabe

Pannier

. Clinical, aetiological, anatomical and pathological classification (CEAP): gold standard and limits. Phlebology 2012; 27(Suppl 1): 114–118.

Hofmann

Deinsberger

Kienzl

, et al. German translation, cross-cultural adaption and validation of the venous clinical severity and venous disability scores. J Patient Rep Outcomes 2023; 7(1): 28.

10.

Labropoulos

Tiongson

Pryor

, et al. Definition of venous reflux in lower-extremity veins. J Vasc Surg 2003; 38: 793–798.

11.

Engin

Ozsin

Savran

, et al. Visceral adiposity index and prognostic nutritional Index in predicting atrial fibrillation after on-pump coronary artery bypass operations: a prospective study. Braz J Cardiovasc Surg 2021; 36(4): 522–529.

12.

Eberhardt

Raffetto

. Chronic venous insufficiency. Circulation 2014; 130: 333–346.

13.

Willenberg

Schumacher

Amann-Vesti

, et al. Impact of obesity on venous hemodynamics of the lower limbs. J Vasc Surg 2010; 52(3): 664–668.

14.

Musil

Kaletova

Herman

. Age, body mass index and severity of primary chronic venous disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2011; 155: 367–371.

15.

Kim

Park

, et al. Alcohol consumption, high-density lipoprotein cholesterol, antithrombin III, and body mass index are associated with great saphenous vein reflux in the thigh. Ann Vasc Surg 2017; 44: 307–316.

16.

Poulose

Deo

Gogineni

, et al. Correlation of venous clinical severity score with dermatology life quality index among patients with chronic venous insufficiency: a cross-sectional study. Cureus 2021; 13(9): e17654.

17.

Yusuf

Hawken

Ounpuu

INTERHEART Study Investigators , et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366(9497): 1640–1649.

18.

Arfvidsson

Eklof

Balfour

. Iliofemoral venous pressure correlates with intraabdominal pressure in morbidly obese patients. Vasc Endovasc Surg 2005; 39(6): 505–509.

19.

Raffetto

Mannello

. Pathophysiology of chronic venous disease. Int Angiol 2014; 33: 212–221.

20.

Coleridge Smith

Thomas

Scurr

, et al. Causes of venous ulceration: a new hypothesis. Br Med J 1988; 296: 1726–1727.

21.

Mosmiller

Steele

Shrader

, et al. Evaluation of inflammatory cell biomarkers in chronic venous insufficiency. Phlebology 2017; 32: 634–640.

22.

Karahan

Yavuz

Kankilic

, et al. Simple blood tests as predictive markers of disease severity and clinical condition in patients with venous insufficiency. Blood Coagul Fibrinolysis 2016; 27: 684–690.

23.

Engin

Goncu

. The role of plateletcrit and neutrophil lymphocyte ratio in showing the clinical severity of the disease in patients with chronic venous insufficiency. Ann Med Res 2020; 27(5): 1475–1490.